Martingale Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $833K | Sell |
|
|||||
|
2024
Q3 | $1.54M | Buy |
|
|||||
|
2024
Q2 | $1.27M | Sell |
|
|||||
|
2024
Q1 | $1.54M | Buy |
|
|||||
|
2023
Q4 | $1.22M | Buy |
|
|||||
|
2023
Q3 | $872K | Buy |
|
|||||
|
2023
Q2 | $830K | Buy |
|
|||||
|
2023
Q1 | $821K | Buy |
|
|||||
|
2022
Q4 | $653K | Buy |
|
|||||
|
2022
Q3 | $390K | Buy |
|
|||||
|
2022
Q2 | $292K | Buy |
|
|||||
|
2022
Q1 | $327K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $237K | Sell |
|
|||||
|
2021
Q1 | $396K | Sell |
|
|||||
|
2020
Q4 | $341K | Sell |
|
|||||
|
2020
Q3 | $1.59M | Buy |
|
|||||
|
2020
Q2 | $548K | Sell |
|
|||||
|
2020
Q1 | $512K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.1M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $888K | Buy |
|
|||||
|
2018
Q4 | $994K | Buy |
|